Clinical Significance of Serum S100 in Metastatic Malignant Melanoma

By Hua B.G.   Stoffel-Wagner B.   Bierwirth T.   Mezger J.   Klingmuller D.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1898-1902

Elsevier

Access to resources Recommend Favorite

Clinical significance of serum S100 in metastatic malignant melanoma

By Guo H.B.   Stoffel-Wagner B.   Bierwirth T.   Mezger J.   Klingmuller D.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 924-928

Elsevier

Access to resources Recommend Favorite

Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma

By Mohammed M.Q.   Abraha H.D.   Sherwood R.A.   MacRae K.   Retsas S.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 109-120

Humana Press, Inc

Access to resources Recommend Favorite

Increased Serum Levels of 5-S-Cysteinyldopa and Intercellular Adhesion Molecule-1 in a Patient with a Uterine Amelanotic Metastasis from a Primary Vaginal Malignant Melanoma

By Suenaga Y.   Katabuchi H.   Okamura H.   Kageshita T.   Ono T.  

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

S-100β Protein – Serum Levels in Children with Brain Neoplasms and its Potential as a Tumor Marker

By Rajendra Anil   Spinella Philip   Drott Henry   Dominguez Troy   Sutton Leslie   Helfaer Mark  

Journal of Neuro-Oncology, Vol. 67, Iss. 3, 2004-05 ,pp. : 345-349

Springer Publishing Company

Access to resources Recommend Favorite